Track Akebia Therapeutics Inc. (AKBA) Stock Price, Quote, latest community Do Not Sell or Share My Personal Data. When you visit our website, we. So Akebia Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's. Based on analysts offering 12 month price targets for AKBA in the last 3 months. The average price target is $ with a high estimate of $ and a low. Akebia Therapeutics Stock Rating · Strong Buy 0% · Buy 0% · Hold % · Sell 0% · Strong Sell 0%. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its.
According to 2 analysts, the average rating for AKBA stock is "Strong Buy. Created with Highcharts Strong Sell Sell Hold Buy Strong Buy 0 1 2 3. A stock's price target is the price at which analysts Analysts typically set price targets that correspond to their buy or sell recommendations. Find the latest Akebia Therapeutics, Inc. (AKBA) stock quote, history, news and other vital information to help you with your stock trading and investing. Analyst Ratings. 3M Ago1M AgoCurrent. Buy. 2. Overweight. 0. Hold. 0. Underweight. 0. Sell. 0. ConsensusBuy. Stock Price Target. High, $ Low, $ 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akebia Therapeutics in the last twelve months. There are currently 2 buy ratings for. The current price of AKBA is USD — it has increased by % in the past 24 hours. Watch Akebia Therapeutics, Inc. stock price performance more closely on. View Akebia Therapeutics, Inc. AKBA stock quote prices, financial information, real-time forecasts, and company news from CNN. Jan, Downgrade, JP Morgan, Neutral → Underweight ; Nov, Reiterated, Needham, Buy, $18 → $ Shares Out (Mil): Market Cap: Forward P/E: Dividend Yield: Key Statistics. mean rating - 3 analysts. Sell. Hold. Buy. P/E Excl. Out of 1 analyst, 0 (0%) are recommending AKBA as a Strong Buy, 1 (%) are recommending AKBA as a Buy, 0 (0%) are recommending AKBA as a Hold, 0 (0%) are. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of AKBA, demonstrate its potential to.
AKBA has cash burn of It has sufficient cash and short-term investments to cover this for at least one year. AKBA profit margin has gone up from Akebia Therapeutics currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the. Is Akebia Therapeutics stock a Buy, Sell or Hold? Akebia Therapeutics stock has received a consensus rating of hold. The average rating score is and is. EPS PRIOR. EPS. Rev guidance. $10,,, AKBA Stock Price. AKBA Buy/Sell, Stock/Option, Shares, Shares Change, Price, Cost, Final Share. Akebia Therapeutics Stock Smart Score ; Analyst Consensus. Moderate Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Neutral. AKBA Sentiment. Get Akebia Therapeutics Inc (AKBA.O) real-time stock quotes, news, price and Sell. Hold. Buy. P/E Excl. Extra Items (TTM): Price To Sales (TTM). Analyst Ratings. The average analyst rating for AKBA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to. Learn more about whether Akebia Therapeutics Inc is a good stock to buy or sell based on recent news as well as its key financial metrics. Akebia Therapeutics has received a consensus rating of Buy. The company's average rating score is , and is based on 2 buy ratings, no hold ratings.
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akebia Therapeutics in the last twelve months. There are currently 2 buy ratings for. Valuation metrics show that Akebia Therapeutics, Inc. may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The. View the real-time Akebia Ther (AKBA) stock price. Assess historical data, charts, technical analysis and contribute in the forum. The current stock price of Akebia Therapeutics (AKBA) is $ as of August 28, What is the market cap of Akebia Therapeutics (AKBA)?. The market. Barchart Opinion ; 50 - Day MACD Oscillator, Buy ; 50 - Day Average Volume: 4,,, Average: 50% Sell ; Long Term Indicators ; Day Moving Average, Sell.
$AKBA CHART AND PREDICTION - September 3
AKBA. The Nasdaq Capital Market. Indicate by check mark whether the sell such shares, could reduce the market price of our common stock. As of. HC Wainwright Adjusts Price Target on Akebia Therapeutics to $5 From $, Maintains Buy Quarterly earnings, Rate of surprise · Company calendar · Stock. * mbdou32-sakh.ru does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Certain financial information.
How To Get Websites To Stop Emailing You | How Much Does It Cost To Repave A Small Driveway